GTC
ZSAN

Ghost Tree Capital’s Zosano Pharma Corporation ZSAN Stock Holding History

Ghost Tree Capital’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,343
Closed -$1.79M – 84
2017
Q1 		$1.79M Buy
+1,343
New +$1.62M 0.33% 59
2015
Q4 		– Sell
-143
Closed -$396K – 75
2015
Q3 		$396K Buy
+143
New +$802K 0.18% 68

Other funds holding ZSAN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ghost Tree Capital's ZSAN Position: Q2 2017 in Review

Ghost Tree Capital sold out of Zosano Pharma Corporation (ZSAN) in Q2 2017, closing a stake of 1,343 shares — an estimated $1.79M sold.

Ghost Tree Capital first reported a position in ZSAN in Q3 2015 and held it in 2 quarters. The position peaked at $1.79M in Q1 2017. 26 funds tracked by Wall St. Rank hold ZSAN as of Q2 2017.

  • Ghost Tree Capital reported no remaining Zosano Pharma Corporation position as of Q2 2017 after selling out during the quarter.
  • Ghost Tree Capital sold 1,343 Zosano Pharma Corporation shares in Q2 2017, an estimated $1.79M.
  • Ghost Tree Capital first reported a position in Zosano Pharma Corporation in Q3 2015 and held it in 2 quarters.
  • Ghost Tree Capital's Zosano Pharma Corporation position peaked at $1.79M in Q1 2017.
  • 26 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2017.

Based on Ghost Tree Capital's 13F filing for Q2 2017, filed 14 Aug 2017.